Marrone Bio Innovations Inc (NASDAQ:MBII) Sentiment Worsened, Despite

Marrone Bio Innovations, Inc. (NASDAQ:MBII) Logo

Sentiment for Marrone Bio Innovations Inc (NASDAQ:MBII)

Marrone Bio Innovations Inc (NASDAQ:MBII) institutional sentiment decreased to 0.94 in 2018 Q4. Its down -1.86, from 2.8 in 2018Q3. The ratio fall, as 16 investment managers increased or opened new holdings, while 17 sold and reduced their stock positions in Marrone Bio Innovations Inc. The investment managers in our partner’s database now possess: 46.51 million shares, up from 46.32 million shares in 2018Q3. Also, the number of investment managers holding Marrone Bio Innovations Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 6 Reduced: 11 Increased: 8 New Position: 8.

Marrone Bio Innovations, Inc. provides bio pest management and plant health products primarily for agricultural and water markets in the United States and internationally. The company has market cap of $190.45 million. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. It currently has negative earnings. The companyÂ’s products include Regalia, a plant extract fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants.

The stock increased 11.69% or $0.18 during the last trading session, reaching $1.72. About 284,826 shares traded or 140.98% up from the average. Marrone Bio Innovations, Inc. (NASDAQ:MBII) has risen 44.14% since May 13, 2018 and is uptrending. It has outperformed by 39.77% the S&P500.

Icm Asset Management Inc Wa holds 0.34% of its portfolio in Marrone Bio Innovations, Inc. for 258,900 shares. Waddell & Reed Financial Inc owns 24.71 million shares or 0.1% of their US portfolio. Moreover, Fairpointe Capital Llc has 0.01% invested in the company for 132,240 shares. The New York-based Spark Investment Management Llc has invested 0.01% in the stock. American International Group Inc, a New York-based fund reported 35,915 shares.

Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $2.35 million activity.

More notable recent Marrone Bio Innovations, Inc. (NASDAQ:MBII) news were published by: Globenewswire.com which released: “Marrone Bio Innovations Named to 2018 Agrow Awards Shortlist – GlobeNewswire” on September 25, 2018, also Nasdaq.com with their article: “Marrone Bio Innovations to Attend Upcoming Investor Conferences in May – Nasdaq” published on May 01, 2019, Globenewswire.com published: “Marrone Bio Innovations, Inc. to Present at 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th – GlobeNewswire” on November 27, 2018. More interesting news about Marrone Bio Innovations, Inc. (NASDAQ:MBII) were released by: Globenewswire.com and their article: “Marrone Bio Innovations Announces Zequanox® Distribution Partnership – GlobeNewswire” published on March 15, 2018 as well as Benzinga.com‘s news article titled: “Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week (March 10-15) – Benzinga” with publication date: March 15, 2019.

Marrone Bio Innovations, Inc. (NASDAQ:MBII) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.